4 patents
Utility
Protocol to Minimize Calcineurin Inhibitor Nephrotoxicity
30 Nov 23
Provided herein are methods of employing pharmacodynamics regimens to maximize effectiveness of voclosporin in treatment of proteinuric kidney diseases while minimizing undesirable side effects, such as but not limited to calcineurin inhibitor nephrotoxicity.
Michael Martin, Robert B. Huizinga, Neil Solomons
Filed: 28 Jul 23
Utility
Protocol for Treatment of Lupus Nephritis
21 Jul 22
By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of a proteinuric kidney disease with voclosporin can be maximized while minimizing undesirable side effects.
Neil SOLOMONS, Robert B. HUIZINGA
Filed: 4 Apr 22
Utility
Ophthalmic Compositions
4 Nov 21
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.
Ashim K. MITRA, Poonam R. VELAGALETI, Subramanian NATESAN
Filed: 12 Apr 21
Utility
Ophthalmic Compositions
8 Jan 20
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.
Ashim K. Mitra, Poonam R. Velagaleti, Subramanian Natesan
Filed: 7 Feb 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first